SQZ BIOTECHNOLOGIES COMPANY Payments for Restructuring
SQZ BIOTECHNOLOGIES COMPANY reported Payments for Restructuring of $2.97 million for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-08.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsForRestructuring · last filed 2023-11-08
- SQZ BIOTECHNOLOGIES COMPANY payments for restructuring for the quarter ending 2023-09-30 was $139.00K.
- SQZ BIOTECHNOLOGIES COMPANY payments for restructuring for the quarter ending 2023-06-30 was $140.00K.
- SQZ BIOTECHNOLOGIES COMPANY payments for restructuring for the quarter ending 2023-03-31 was $2.69M.
- SQZ BIOTECHNOLOGIES COMPANY payments for restructuring for fiscal 2022 was $895.00K.
| Period end | Payments for Restructuring 3 month | Payments for Restructuring 6 month | Payments for Restructuring 9 month | Payments for Restructuring 12 month |
|---|---|---|---|---|
| 2023-09-30 | $139.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $279.00K derived: sum of 2 quarters · filed 2023-11-08 | $2.97M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $140.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $2.83M 10-Q · filed 2023-08-10 | ||
| 2023-03-31 | $2.69M 10-Q · filed 2023-05-10 | |||
| 2022-12-31 | $895.00K 10-K · filed 2023-03-22 |